Regeneron Pharmaceuticals, Inc. (REGN Quick QuoteREGN - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $336.18 to $406.30 in the past one-month time frame.

The company has seen two negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Regeneron currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is negative.

Regeneron Pharmaceuticals, Inc. Price

Investors interested in the Medical - Biomedical and Genetics industry may consider Guardant Health, Inc. (GH Quick QuoteGH - Free Report) , which also has a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Is REGN going up? Or down? Predict to see what others think:Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>